BMO Capital analyst Rene Cartier initiated coverage of Firefly Metals (MNXMF) with an Outperform rating and A$1.75 price target FireFly is ...
BMO Capital raised the firm’s price target on HubSpot (HUBS) to $885 from $690 and keeps an Outperform rating on the shares. The company ...
B2Gold (TSX: BTO) has upped its investment in Founders Metals (TSXV: FDR) to maintain its 5% shareholding, in response to the ...
Green Plains (NASDAQ:GPRE – Get Free Report) had its target price cut by BMO Capital Markets from $13.00 to $8.00 in a ...
BMO Capital Markets. "As the industry evolves, our priority is providing exceptional service to our clients while delivering more integrated and innovative solutions to grow our market leading ...
Arvinas (NASDAQ:ARVN – Get Free Report)‘s stock had its “outperform” rating reiterated by BMO Capital Markets in a research report issued to clients and investors on Wednesday,Benzinga reports. They ...
BMO Capital Markets adjusted their outlook on DuPont (NYSE:DD), increasing the price target from the previous $105.00 to a ...
In early February, the Vancouver-based explorer announced a C$30 million bought deal financing by a group of underwriters led ...
Signs of resurgent inflation shown in January's consumer-price index can't be "easily explained away" by seasonal factors, and pressure will build on the Federal Reserve to stay on hold for a ...
On Tuesday, BMO Capital Markets reaffirmed their Outperform rating on Beam Therapeutics Inc (NASDAQ:BEAM), with a steady price target of $57.00. Currently trading at $26.57, the stock appears ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results